Thursday, October 15, 2020

Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO

Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.

from NDTV News - Latest https://ift.tt/3nX8fwP
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Amid Drug Price Cuts, A Look At India's Cancer Burden Against Asian Peers

India records around 1.56 million cancer cases and 9,02,000 deaths in 2025, making it the second-most affected country among selected Asian ...